PCORI Awards $14M To Study Aspirin's Use In Preventing Heart Attacks, Strokes

The Patient-Centered Outcomes Research Institute (PCORI) awarded $14 million for a three-year clinical trial headed by Duke University researchers to determine the best dose of aspirin to use as a preventative against heart attacks and strokes for people with heart disease. Aspirin has been used as a daily treatment in both regular doses and low-doses, known as “baby aspirin,” to prevent heart attacks and strokes in people with heart disease. But PCORI officials point out that aspirin can cause serious...